Literature DB >> 11440405

Self-perceived health status of Irish breast cancer survivors.

M B O'Sullivan1.   

Abstract

BACKGROUND: There is a paucity of data on the health status of breast cancer survivors. AIMS: To measure the self-perceived health status of a cohort of breast cancer survivors by means of the SF-36 questionnaire.
METHODS: The questionnaire was administered to 120 survey participants. Findings were compared with those of an external comparison group.
RESULTS: The health status of the survey participants was found to be significantly better than that of the comparison group on four of the eight SF-36 dimensions--social functioning, mental health, vitality and general health perceptions.
CONCLUSIONS: The self-perceived health status of breast cancer survivors merits further research in the Irish context. Inclusion of the SF-36 questionnaire as an outcome measure is recommended.

Entities:  

Mesh:

Year:  2001        PMID: 11440405     DOI: 10.1007/BF03167713

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   2.089


  3 in total

1.  Measuring health status with the SF-36: the need for regional norms.

Authors:  R A Lyons; H Fielder; B N Littlepage
Journal:  J Public Health Med       Date:  1995-03

2.  Breast cancer survivors: psychosocial concerns and quality of life.

Authors:  P A Ganz; A Coscarelli; C Fred; B Kahn; M L Polinsky; L Petersen
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 3.  Quality-of-life research in patients with breast cancer.

Authors:  E P Winer
Journal:  Cancer       Date:  1994-07-01       Impact factor: 6.860

  3 in total
  2 in total

1.  Breast cancer survivors' supportive care needs 2-10 years after diagnosis.

Authors:  Katharine Hodgkinson; Phyllis Butow; Glenn E Hunt; Susan Pendlebury; Kim M Hobbs; Gerard Wain
Journal:  Support Care Cancer       Date:  2006-11-21       Impact factor: 3.603

2.  Outcome in breast cancer.

Authors:  A D Hill
Journal:  Ir J Med Sci       Date:  2001 Jan-Mar       Impact factor: 2.089

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.